Roshon Therapeutics is a private biotechnology company dedicated to discovering and developing novel therapeutics for the treatment of patients with cancer and inflammatory diseases. Our team of researchers, clinicians and drug developers is committed to understanding the underlying mechanisms of these diseases and developing innovative treatments to improve patient outcomes.